Business, energy, technology, markets and global industry news from Business News Today

REDEFINE 1

Pharma & Biotech

CagriSema delivered 25% weight loss in early responders. What does that reveal about Novo Nordisk’s obesity drug?

Novo Nordisk reports 25.4% CagriSema weight loss among early responders. Discover what the post hoc analysis means before its FDA decision.

Read More